Abstract Library

The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.

1

Effectiveness of ergonomic interventions on work activity limitations in adults with rheumatoid arthritis: A systematic review

Work. 2022 Jul 23. doi: 10.3233/WOR-210016. Online ahead of print.

 

Heather Jones 1Megan Young 1Kyndel Guyton 1Emily Idemoto 1Alicia Ferraro 1Rawan AlHeresh 1

2

Examining the Relationship Between Rheumatoid Arthritis, Multimorbidity, and Adverse Health-Related Outcomes: A Systematic Review

Arthritis Care Res (Hoboken). 2022 Sep;74(9):1500-1512. doi: 10.1002/acr.24587.Epub 2022 May 27.

 

Jordan Canning 1Stefan Siebert 1Bhautesh D Jani 1Louisa Harding-Edgar 1Isla Kempe 1Frances S Mair 1Barbara I Nicholl 1

3

Clinical prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: A systematic review and meta-analysis

Semin Arthritis Rheum. 2022 Oct;56:152076. doi: 10.1016/j.semarthrit.2022.152076.Epub 2022 Jul 27.

 

Celina K Gehringer 1Glen P Martin 2Kimme L Hyrich 3Suzanne M M Verstappen 3Jamie C Sergeant 4

4

Acute effects of exercise on pain symptoms, clinical inflammatory markers and inflammatory cytokines in people with rheumatoid arthritis: a systematic literature review

Ther Adv Musculoskelet Dis. 2022 Aug 16;14:1759720X221114104.doi: 10.1177/1759720X221114104. eCollection 2022.

 

Christopher Balchin 1Ai Lyn Tan 2Joshua Golding 1Lesley-Anne Bissell 2Oliver J Wilson 1Jim McKenna 1Antonios Stavropoulos-Kalinoglou 3

5

Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program

Rheumatology (Oxford). 2022 Aug 3;61(8):3246-3256.doi: 10.1093/rheumatology/keab861.

 

Charles G Peterfy 1Vibeke Strand 2Alan Friedman 3Stephen Hall 4Eduardo Mysler 5Patrick Durez 6Xenofon Baraliakos 7Jeffrey V Enejosa 3Tim Shaw 3Yihan Li 3Su Chen 3In-Ho Song 3

6

A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis

Semin Arthritis Rheum. 2022 Oct;56:152072.doi: 10.1016/j.semarthrit.2022.152072. Epub 2022 Jul 16.

 

Maria A Lopez-Olivo 1Jessica T Foreman 2Cheuk Leung 3Heather Y Lin 3Tiffany Westrich-Robertson 4Catherine Hofstetter 5Jude K A des Bordes 6Anne Lyddiatt 7Amye Leong 8Irmgard U Willcockson 9Susan K Peterson 10Maria E Suarez-Almazor 11

7

Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis

N Engl J Med. 2022 Aug 25;387(8):715-726. doi: 10.1056/NEJMoa2201302.

 

Josef S Smolen 1Eugen Feist 1Saeed Fatenejad 1Sergey A Grishin 1Elena V Korneva 1Evgeniy L Nasonov 1Mikhail Y Samsonov 1Roy M Fleischmann 1CREDO2 GroupCREDOZ Group

 

Collaborators

8

Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial

J Intern Med. 2022 Sep;292(3):477-491.doi: 10.1111/joim.13495. Epub 2022 Apr 26.

 

Marthe Kirkesaether Brun 1 2Guro Løvik Goll 1Kristin Kaasen Jørgensen 3Joseph Sexton 1Johanna Elin Gehin 2 4Øystein Sandanger 5Inge Christoffer Olsen 6Rolf Anton Klaasen 4David John Warren 4Cato Mørk 7Tore K Kvien 1 2Jørgen Jahnsen 2 3Nils Bolstad 4Espen A Haavardsholm 1 2Silje Watterdal Syversen 1

9

Discrepancy Between Multibiomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis

Arthritis Care Res (Hoboken). 2022 Sep;74(9):1477-1483.doi: 10.1002/acr.24583. Epub 2022 May 24.

 

Roy Fleischmann 1Jingyu Liu 2Julie Zhu 2Oscar G Segurado 3Daniel E Furst 4

10

Treatment Guidelines in Rheumatoid Arthritis

Rheum Dis Clin North Am. 2022 Aug;48(3):679-689. doi: 10.1016/j.rdc.2022.03.005.Epub 2022 Jul 5.

 

Jasvinder A Singh 1

11

'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps

RMD Open. 2022 Jul;8(2):e002387. doi: 10.1136/rmdopen-2022-002387.

 

Yvonne Tan 1Maya H Buch 2 3

12

What is the impact of sex hormones on the pathogenesis of rheumatoid arthritis?

Front Med (Lausanne). 2022 Jul 22;9:909879. doi: 10.3389/fmed.2022.909879.eCollection 2022.

 

Charles Raine 1Ian Giles 1

13

Cost-effectiveness of motivational counselling and text reminders in patients with rheumatoid arthritis: results based on a randomised clinical trial

RMD Open. 2022 Jul;8(2):e002304.doi: 10.1136/rmdopen-2022-002304.

 

Jan Sørensen 1 2Bente Appel Esbensen 3 4Mette Aadahl 4 5Merete Lund Hetland 6 7Tanja Thomsen 5 8

14

Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies

EBioMedicine. 2022 Jul 8;82:104154. doi: 10.1016/j.ebiom.2022.104154. Online ahead of print.

 

Susanna C Larsson 1Stephen Burgess 2

15

Methotrexate Cutaneous Ulceration: A Systematic Review of Cases

Am J Clin Dermatol. 2022 Jul;23(4):449-457. doi: 10.1007/s40257-022-00692-1.Epub 2022 Apr 29.

 

Ronald Berna 1Misha Rosenbach 1David J Margolis 1 2Nandita Mitra 1 2Emily Baumrin 3

16

Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders

Front Immunol. 2022 Jul 6;13:888392. doi: 10.3389/fimmu.2022.888392. eCollection 2022.

 

Dennis D Arnold 1Ayla Yalamanoglu 1Onur Boyman 1 2

17

Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis

Ann Rheum Dis. 2022 Jul;81(7):937-943. doi: 10.1136/annrheumdis-2022-222338.Epub 2022 Apr 25.

 

Lotte van Ouwerkerk 1Andriko Palmowski 2Isabell S Nevins 3Frank Buttgereit 2Patrick Verschueren 4Josef S Smolen 5Robert Bm Landewé 6 7Johannes Jw Bijlsma 8Andreas Kerschbaumer 5René Westhovens 4Tom Wj Huizinga 3Cornelia F Allaart 3Sytske Anne Bergstra 3

18

Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritis

Rheumatology (Oxford). 2022 Jul 6;61(7):2815-2825.doi: 10.1093/rheumatology/keab839.

 

Paul Studenic 1 2Gregor Bond 3Andreas Kerschbaumer 1Manuel Bécède 1Karel Pavelka 4 5Dmitry Karateev 6Jutta Stieger 7Rudolf Puchner 8Ruediger B Mueller 9Elisabeth Puchhammer-Stöckl 10Martina Durechova 1Michaela Loiskandl 1Thomas Perkmann 11Martina Olejarova 4 5Elena Luchikhina 6Carl-Walter Steiner 1Michael Bonelli 1Josef S Smolen 1Daniel Aletaha 1

19

Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data

Arthritis Res Ther. 2022 Jul 1;24(1):162.doi: 10.1186/s13075-022-02851-5.

 

Stephanie Q Duong 1Cynthia S Crowson 1 2Arjun Athreya 3Elizabeth J Atkinson 1John M Davis 3rd 2Kenneth J Warrington 2Eric L Matteson 2Richard Weinshilboum 3Liewei Wang 3Elena Myasoedova 4 5

20

Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

Ann Rheum Dis. 2022 Jul;81(7):925-936.doi: 10.1136/annrheumdis-2021-221957. Epub 2022 May 31.

 

Maarten Boers 1 2Linda Hartman 3 2Daniela Opris-Belinski 4Reinhard Bos 5Marc R Kok 6Jose Ap Da Silva 7Eduard N Griep 8Ruth Klaasen 9Cornelia F Allaart 10Paul Baudoin 11Hennie G Raterman 12Zoltan Szekanecz 13Frank Buttgereit 14Pavol Masaryk 15L Thomas Klausch 3Sabrina Paolino 16Annemarie M Schilder 5Willem F Lems 2Maurizio Cutolo 16GLORIA Trial consortium

21

Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritis

Mod Rheumatol. 2022 Jul 1;32(4):696-707. doi: 10.1093/mr/roab058.

 

Yoshiya Tanaka 1Tsutomu Takeuchi 2Daisuke Kato 3Yuichiro Kaneko 3Musashi Fukuda 3Daisuke Miyatake 3

22

Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial

Lancet. 2022 Jul 23;400(10348):283-294.doi: 10.1016/S0140-6736(22)01193-X.

 

Doortje I Krijbolder 1Marloes Verstappen 1Bastiaan T van Dijk 1Yousra J Dakkak 1Leonie E Burgers 1Aleid C Boer 1Yune Jung Park 2Marianne E de Witt-Luth 3Karen Visser 4Marc R Kok 5Esmeralda T H Molenaar 6Pascal H P de Jong 7Stefan Böhringer 8Tom W J Huizinga 1Cornelia F Allaart 1Ellis Niemantsverdriet 1Annette H M van der Helm-van Mil 9

23

Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study

Ann Rheum Dis. 2022 Jun;81(6):798-804.doi: 10.1136/annrheumdis-2021-221915. Epub 2022 Jan 13.

 

Farzin Khosrow-Khavar 1Seoyoung C Kim 1 2Hemin Lee 1Su Been Lee 1Rishi J Desai 3

24

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Nat Med. 2022 Jun;28(6):1256-1268. doi: 10.1038/s41591-022-01789-0.Epub 2022 May 19.

 

Felice Rivellese # 1 2Anna E A Surace # 1 2Katriona Goldmann 1 2Elisabetta Sciacca 1 2Cankut Çubuk 1 2Giovanni Giorli 1 2Christopher R John 1 2Alessandra Nerviani 1Liliane Fossati-Jimack 1Georgina Thorborn 1Manzoor Ahmed 1Edoardo Prediletto 1Sarah E Church 3Briana M Hudson 3Sarah E Warren 3Paul M McKeigue 4Frances Humby 1Michele Bombardieri 1Michael R Barnes 2Myles J Lewis 5 6Costantino Pitzalis 7R4RA collaborative group

25

Patient involvement in rheumatoid arthritis care to improve disease activity-based management in daily practice: A randomized controlled trial

Patient Educ Couns. 2022 May;105(5):1244-1253.doi: 10.1016/j.pec.2021.08.013. Epub 2021 Aug 14.

 

Marieke J Spijk-de Jonge 1Julia M Weijers 2Steven Teerenstra 3Glyn Elwyn 4Mart Afj van de Laar 5Piet Lcm van Riel 6Anita Mp Huis 2Marlies Ejl Hulscher 2

26

Different types of foot orthoses effect on gait mechanics in patients with rheumatoid arthritis

J Biomech. 2022 Jun;139:110496.doi: 10.1016/j.jbiomech.2021.110496. Epub 2021 Apr 30.

 

Morten Bilde Simonsen 1Rogerio Pessoto Hirata 2Ketill Næsborg-Andersen 3Peter Derek Christian Leutscher 4Kim Hørslev-Petersen 5James Woodburn 6Michael Skipper Andersen 7

27

Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients-results from a randomized controlled trial

Arthritis Res Ther. 2022 May 25;24(1):125.doi: 10.1186/s13075-022-02809-7.

 

Johannes Knitza 1 2 3Koray Tascilar 4 5Nicolas Vuillerme 6 7 8Ekaterina Eimer 9Paul Matusewicz 9Giulia Corte 4 5Louis Schuster 4 5Timothée Aubourg 6 8Gerlinde Bendzuck 10Marianne Korinth 10Corinna Elling-Audersch 10Arnd Kleyer 4 5Sebastian Boeltz 4 5Axel J Hueber 4 11Gerhard Krönke 4 5Georg Schett 4 5David Simon 4 5

28

Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review

RMD Open. 2022 Apr;8(1):e002058. doi: 10.1136/rmdopen-2021-002058.

 

Mrinalini Dey 1 2Amanda Busby 3Helen Elwell 4Heidi Lempp 5Arthur Pratt 6 7Adam Young 3John Isaacs 6 7Elena Nikiphorou 5 8

29

Psychological stress in rheumatoid arthritis: a systematic scoping review

Semin Arthritis Rheum. 2022 Apr 21;55:152014.doi: 10.1016/j.semarthrit.2022.152014. Online ahead of print.

 

Diederik De Cock 1Michaël Doumen 2Charlotte Vervloesem 3Annelies Van Breda 3Delphine Bertrand 3Sofia Pazmino 3René Westhovens 4Patrick Verschueren 4

30

Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options

Clin Rheumatol. 2022 Apr;41(4):1247-1254. doi: 10.1007/s10067-022-06062-w.Epub 2022 Jan 14.

 

Riccardo Bixio 1Davide Bertelle 2Francesca Pistillo 2Elisa Pedrollo 2Antonio Carletto 2Maurizio Rossini 2Ombretta Viapiana 2

31

The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis

J Clin Rheumatol. 2022 Mar 1;28(2):e407-e414.doi: 10.1097/RHU.0000000000001749.

 

Carlos Alves 1Ana Penedones 2Diogo Mendes 2Francisco Batel Marques 1

32

Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies

RMD Open. 2022 May;8(1):e002103. doi: 10.1136/rmdopen-2021-002103.

 

Ara H Dikranian 1Miguel A Gonzalez-Gay 2Frank Wellborne 3José María Álvaro-Gracia 4Liza Takiya 5Lori Stockert 5Jerome Paulissen 6Harry Shi 6Svitlana Tatulych 7Jeffrey R Curtis 8

33

Blood PD-1+TFh and CTLA-4+CD4+ T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis

Rheumatology (Oxford). 2022 Mar 2;61(3):1233-1242.doi: 10.1093/rheumatology/keab454.

 

Jonathan Aldridge 1Kerstin Andersson 1Inger Gjertsson 1Anna-Karin Hultgård Ekwall 1Magnus Hallström 1Ronald van Vollenhoven 2Anna-Carin Lundell 1Anna Rudin 1

34

An Exercise and Educational and Self-management Program Delivered With a Smartphone App (CareHand) in Adults With Rheumatoid Arthritis of the Hands: Randomized Controlled Trial

JMIR Mhealth Uhealth. 2022 Apr 7;10(4):e35462.doi: 10.2196/35462.

 

Pablo Rodríguez Sánchez-Laulhé 1 2Luis Gabriel Luque-Romero 3 4Francisco José Barrero-García 3Ángela Biscarri-Carbonero 3Jesús Blanquero 1Alejandro Suero-Pineda 1Alberto Marcos Heredia-Rizo 1 2

35

The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids

Arthritis Rheumatol. 2022 Apr;74(4):604-611. doi: 10.1002/art.41981.Epub 2022 Feb 13.

 

Kenneth G Saag 1Michele T McDermott 2Jonathan Adachi 3Willem Lems 4Nancy E Lane 5Piet Geusens 6Robert Kees Stad 2Li Chen 2Shuang Huang 2Robin Dore 7Stanley Cohen 8

36

Pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial

Expert Rev Clin Immunol. 2022 May;18(5):533-543.doi:10.1080/1744666X.2022.2060204. Epub 2022 Apr 10.

 

Christian Schwabe 1Andras Illes 2Martin Ullmann 2Vishal Ghori 2Emmanuelle Vincent 2Corinne Petit-Frere 2Joelle Monnet 2Anne Sophie Racault 2Chris Wynne 3

37

Effectiveness and cost-effectiveness of longstanding exercise therapy versus usual care in patients with axial spondyloarthritis or rheumatoid arthritis and severe limitations: The protocols of two parallel randomized controlled trials

Physiother Res Int. 2022 Jan;27(1):e1933.doi: 10.1002/pri.1933. Epub 2021 Nov 15.

 

Maria A T van Wissen 1Max M H Teuwen 1Cornelia H M van den Ende 2 3Thea P M Vliet Vlieland 1Alfons A den Broeder 2 3Wilbert B van den Hout 4Wilfred F Peter 1Dirkjan van Schaardenburg 5Astrid M van Tubergen 6 7Maaike G J Gademan 1 8Salima F E van Weely 1

38

Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3)

Mod Rheumatol. 2022 Feb 28;32(2):273-283. doi: 10.1093/mr/roab021.

 

Tatsuya Atsumi 1Yoshiya Tanaka 2Tsukasa Matsubara 3Koichi Amano 4Naoki IshiguroEiji Sugiyama 5Kunihiro Yamaoka 6René Westhovens 7Daniel W T Ching 8Osvaldo Daniel Messina 9Gerd R Burmester 10Beatrix Bartok 11Alena Pechonkina 11Akira Kondo 12Zhaoyu Yin 11Ying Guo 11Chantal Tasset 13John S Sundy 11 14 15Tsutomu Takeuchi 16

39

Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study

RMD Open. 2022 Jan;8(1):e002013.doi: 10.1136/rmdopen-2021-002013.

 

Nina Paulshus Sundlisæter 1Ulf Sundin 2Anna-Birgitte Aga 2Joseph Sexton 2Hilde Berner Hammer 2 3Till Uhlig 2 3Tore K Kvien 2 3Espen A Haavardsholm 2 3Siri Lillegraven 2

40

Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B Cells

Arthritis Rheumatol. 2022 Feb;74(2):200-211. doi: 10.1002/art.41941.Epub 2021 Dec 27.

 

Nida Meednu 1Jennifer Barnard 1Kelly Callahan 1Andreea Coca 1Bethany Marston 1Ralf Thiele 1Darren Tabechian 1Marcy Bolster 2Jeffrey Curtis 3Meggan Mackay 4Jonathan Graf 5Richard Keating 6Edwin Smith 2Karen Boyle 7Lynette Keyes-Elstein 7Beverly Welch 8Ellen Goldmuntz 8Jennifer H Anolik 1

41

Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND

J Rheumatol. 2022 Feb;49(2):133-141. doi: 10.3899/jrheum.210346.Epub 2021 Sep 15.

 

Désirée van der Heijde 1Cynthia E Kartman 2Li Xie 3Scott Beattie 4Douglas Schlichting 5Daojun Mo 4Patrick Durez 6Yoshiya Tanaka 7Roy Fleischmann 8

42

Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE

Rheumatology (Oxford). 2021 Dec 1;60(12):5583-5594.doi: 10.1093/rheumatology/keab158.

 

Vibeke Strand 1Namita Tundia 2Martin Bergman 3Andrew Ostor 4Patrick Durez 5In-Ho Song 2Jeffrey Enejosa 2Casey Schlacher 2Yan Song 6Roy Fleischmann 7

43

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis

N Engl J Med. 2022 Jan 27;386(4):316-326.doi: 10.1056/NEJMoa2109927.

 

Steven R Ytterberg 1Deepak L Bhatt 1Ted R Mikuls 1Gary G Koch 1Roy Fleischmann 1Jose L Rivas 1Rebecca Germino 1Sujatha Menon 1Yanhui Sun 1Cunshan Wang 1Andrea B Shapiro 1Keith S Kanik 1Carol A Connell 1ORAL Surveillance Investigators

Collaborators

ORAL Surveillance Investigators: 

Steven R Ytterberg, Deepak L Bhatt, Ted R Mikuls, Gary G Koch, Alejandro Alvarellos, Analia Alvarez, Alberto Berman, Maria Correa, Rodolfo Pardo Hidalgo, Maria Lazaro, Pablo Maid, Leonardo Naftal, Bernardo Pons-Estel, Guillermo Tate, Russell Buchanan, Maureen Rischmueller, Evangelos Romas, Robert Will, Ana Paula Assad, Valderilio Feijo Azevedo, Rubens Bonfiglioli, William Chahade, Celso Ricardo de Abreu, Ricardo de Toledo, Ari Halpern, Adriana Maria Kakehasi, Flora Marcolino, Ana Claudia Melazzi, Tatiana Muller, Mittermayer Santiago, Morton Scheinberg, Antonio Scotton, Ricardo Xavier, Cristiano Zerbini, Vladimir Kadinov, Nikolay Nikolov, Yuliy Spasov, Rumen Stoilov, Nadezhda Yordanova, Milton Baker, Isabelle Fortin, Algis Jovaisas, Clode Lessard, Jude Rodrigues, Alexander Yan, Irmgadt Goecke Sariego, Mirentxu Ines Iruretagoyena Bruce, Maria Martinez Ruiz-Esquide, Lucia Ponce Lerou, Xiao Zhang, Carlos Arteaga Unigarro, John Londono Patino, Jose Molina Restrepo, William Otero Escalante, Federico Rondon Herrera, Patricia Velez-Sanchez, Ladislav Bortlik, Šárka Forejtová, Zdenka Mosterova, Petr Nemec, Libor Novosad, Vlastimil Racek, Jan Rosa, Zuzana Stejfova, Petr Vitek, Pentti Jarvinen, Heikki Valleala, Tsang Tommy Cheung, Chak Sing Lau, Ka Lai Lee, Chi-Chiu Mok, Lai Shan Tam, Howard Amital, Alexandra Balbir-Gurman, Ori Elkayam, Yair Levy, Merav Lidar, Andrey Markov, Dror Mevorach, Yair Molad, Tatiana Reitblat, Itzhak Rosner, Moshe Tishler, Devy Zisman, Khaldoon Alawneh, Jeries Daoud, Nadeen Hilal, Jeanine Menassa, Nelly Ziade, Ping Seung Ong, Azmillah Rosman, Wahinuddin Sulaiman, Cheng Lay The, Carlos Abud-Mendoza, Hilario Avila Armengol, Mario Cardiel Rios, Sandra Carillo Vazquez, Rafael Cornejo-Ballesteros, Jose Covarrubias Cobos, Sergio Gutierrez-Urena, Fedra Irazoque-Palazuelos, Marco Maradiaga Cecena, Cesar Pacheco-Tena, Virginia Pascual-Ramos, Juan Rizo Rodriguez, Isaura Rodriguez Torres, Reinhard Bos, Jacob Van Laar, Daniel Ching, Alan Doube, Sunil Kumar, Ketna Parekh, Ana Marisela Asmat Anhuaman, Alfredo Berrocal Kasay, Armando Calvo Quiroz, Jose Chavez Corrales, Elias Chalouhi El Khouri, Boris Garro Barrera, Manuel Leon-Portocarrero, Alejandro Miranda Pinto, Risto Perich Campos, Félix Romero Peña, Jan Brzezicki, Dariusz Chudzik, Magdalena Dmoszynska-Graniczka, Krystyna Dworak, Barbara Grabowicz-Wasko, Pawel Hrycaj, Slawomir Jeka, Marek Konieczny, Marek Krogulec, Jaroslaw Marcinkiewicz, Agnieszka Ewa Pawtel, Artur Racewicz, Maria Rell-Bakalarska, Zofia Ruzga, Karina Sitek-Ziolkowska, Maria Stopinska-Polaszewska, Anna Sylwestrzak, Leszek Szczepanski, Piotr Wiland, Agnieszka Zielinska, Grisell Ortiz-Lasanta, Jose Ramirez-Vazquez, Ramon Toro Torres, Alina Agafina, Grigory Arutyunov, Valeria Esip, Elena Grunina, Nadezhda Izmozherova, Natalya Khalaydzhi, Irina Marusenko, Tatyana Mikhaylova, Andrey Sarana, Ivan Shirinsky, Evgeniya Shmidt, Olga Stetsiouk, Peter Belica, Livia Bruskova, Pavol Dobrovodsky, Viola Husarova, Roman Jancovic, Andrea Skublova, Agnesa Szolnokiova, Johannes Breedt, Maria Du Plooy, Dina Janse Van Rensburg, Asgar Kalla, Faruq Khatib, Ingrid Louw, Savithree Nayiager, Jeanne Nel, Jennifer Potts, Helmuth Reuter, Catherine Spargo, Gareth Tarr, Elsa Van Duuren, Ricardo Blanco Alonso, Ivan Castellvi Barranco, Eugenio Chamizo Carmona, Antonio Fernandez Nebro, Maria Luz Garcia Vivar, Beatriz Joven Ibanez, Isabel Mateo Bernardo, Elisabet Montori Palacin, Carmen Moragues Pastor, Alberto Alonso Ruiz, Federico Navarro Sarabia, Jose Javier Perez Venegas, Manuel Enrique Pombo Suarez, Eduardo Ucar Angulo, Carmen Vargas Lebron, Ying-Ming Chiu, Chien-Chih Lai, Ning-Sheng Lai, Joung-Liang Lan, Hsiao-Yi Lin, Ming-Fei Liu, Mei-Ping Liu, Shue-Fen Luo, Ya-Chih Tien, Cheng-Chung Wei, Chia-Tse Weng, Paijit Asavatanabodee, Wanruchada Katchamart, Worawit Louthrenoo, Kanokrat Nantiruj, Boonjing Siripaitoon, Sebnem Ataman, Ayse Erguney Cefle, Savas Gursoy, Gulen Hatemi, Sami Hizmetli, Umut Kalyoncu, Omer Karadag, Senol Kobak, Omer Kuru, Ahmet Onat, Ali Taylan, Yasemin Turan, Hasan Ulusoy, Orhan Zengin, Teresa Doherty, Robert Moots, Wan Fai Ng, Selwyn Richards, Euthalia Roussou, Thomas Sheeran, David Walker, Jacob Aelion, Jeffrey Alloway, Cristina Arriens, Kwabena Ayesu, Herbert Baraf, Linda Belhorn, Anupama Bhat, Barbara Bode, Stephen Bookbinder, Mark Box, Timothy Brennan, James Calmes, Robert Capps, John Carter, Anurekha Chadha, Victor Chen, Melvin Churchill, Andreea Coca, Asif Cochinwala, Christine Codding, Jeffrey Curtis, Kathryn Dao, Craig Davis, John Davis, Nimesh Dayal, Belkis Delgado, Roger Diegel, Ara Dikranian, Erdal Diri, Geoffrey Dolan, Robin Dore, Sharon Dowell, Michelle Eisenberg, Mitchell Feinman, Justus Fiechtner, Beata Filip-Majewski, Joseph Forstot, Pamela Freeman, David Goddard, Marc Goldberg, Misael Gonzalez, John Gorman, Maria Greenwald, Robert Griffin, Ramesh Gupta, Dale Halter, Robert Harrell, Mark Harris, John Harshbarger, Douglas Haselwood, Sabine Hazan-Steinberg, Ammar Hemaidan, Geneva Hill, Diane Horowitz, Mary Howell, John Hull, Richard Jones, John Joseph, Vipul Joshi, Joshua June, Gurjit Kaeley, Kenneth Kalunian, George Karpouzas, Paul Katzenstein, Ratinder Kaur, Jonathan Kay, Kimberly Kendall, William Kim, Alan Kivitz, Steven Klein, Michael Kohen, Chian Kwoh, Robert LaGrone, Jeffrey Lawson, Clarence Legerton, Robert Levin, Roger Lidman, Jefrey Lieberman, Jeffrey Lisse, Mitchell Lowenstein, Michael Luggen, Basit Malik, Jyothi Mallepalli, Joan Merrill, Samy Metyas, Wesley Mizutani, Joseph Moran, Sabeen Najam, Nathaniel Neal, Tony Ning, Ghaith Noaiseh, Kurt Oelke, Ewa Olech, Meera Oza, Dennis Ozment, William Palmer, Dayton Payne, Samuel Pegram, Dianne Petrone, Jeffrey Poiley, Andrew Porges, Henry Prupas, Madura Rangaraj, Ronald Rapoport, Andreas Reimold, David Ridley, Jeffrey Ritter, Georgia Roane, Michael Robinson, Adam Rosen, Constantine Saadeh, Michael Sayers, William Schnitz, Anthony Sebba, William Shergy, Robert Shurmur, David Sikes, Atul Singhal, Yvonne Smallwood-Sherrer, Nowarat Songsiridej, Michael Stack, Melody St John, William Stohl, Tien-I Su, Dominick Sudano, Andrew Sulich, Prashanth Sunkureddi, Paul Sutej, Timothy Swartz, Suman Thakker, Aikaterini Thanou, Robert Trapp, Orrin Troum, David True, Yong-Hsiung Tsai, James Udell, Fehmida Zahabi Unwala, Jacqueline Vo, Philip Waller, Saleem Waraich, Nathan Wei, Charles Weidmann, Craig Wiesenhutter, Anne Winkler, Sanford Wolfe, Darice Yang, Karen Zagar

44

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis

Front Immunol. 2021 Nov 18;12:729681.doi: 10.3389/fimmu.2021.729681. eCollection 2021.

Liam J O'Neil 1 2Pingzhao Hu 3 4Qian Liu 3 4Md Mohaiminul Islam 3 4Victor Spicer 2Juergen Rech 5Axel Hueber 5Vidyanand Anaparti 2Irene Smolik 1Hani S El-Gabalawy 1 2Georg Schett 5John A Wilkins 1 2

45

Effects of a Weight and Pain Management Program in Patients With Rheumatoid Arthritis With Obesity: A Randomized Controlled Pilot Investigation

J Clin Rheumatol. 2022 Jan 1;28(1):7-13.doi: 10.1097/RHU.0000000000001793.

Tamara J Somers 1James A Blumenthal 1Caroline S Dorfman 1Kim M Huffman 2Sara N EdmondShannon N Miller 1Anava A Wren 3David Caldwell 4Francis J Keefe 1

46

Evaluating filgotinib for the treatment of rheumatoid arthritis

Expert Opin Pharmacother. 2021 Dec;22(18):2435-2444.doi: 10.1080/14656566.2021.1967929. Epub 2021 Aug 26.

Christophe Richez 1 2Marie-Elise Truchetet 1 2

47

Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits

Arthritis Care Res (Hoboken). 2021 Dec;73(12):1809-1814. doi: 10.1002/acr.24429.

Bryant R England 1Claire E H Barber 2Martin Bergman 3Veena K Ranganath 4Lisa G Suter 5Kaleb Michaud 6

48

The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial

Arthritis Rheumatol. 2021 Dec;73(12):2206-2218.doi: 10.1002/art.41953. Epub 2021 Nov 1.

Aaron Winkler 1Weiyong Sun 1Saurav De 2Aiping Jiao 1M Nusrat Sharif 1Peter T Symanowicz 1Shruti Athale 3Julia H Shin 1Ju Wang 1Bruce A Jacobson 1Simeon J Ramsey 1Ken Dower 1Tatyana Andreyeva 1Heng Liu 1Martin Hegen 1Bruce L Homer 1Joanne Brodfuehrer 1Mera Tilley 1Steven A Gilbert 1Spencer I Danto 1Jean J Beebe 1Betsy J Barnes 2Virginia Pascual 3Lih-Ling Lin 1Iain Kilty 1Margaret Fleming 1Vikram R Rao 1

49

The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies

Arthritis Res Ther. 2022 Jan 3;24(1):11. doi: 10.1186/s13075-021-02677-7.

Clifton O Bingham 3rd 1David Walker 2Peter Nash 3Susan J Lee 4Lei Ye 4Hao Hu 4Javaria Mona Khalid 5Bernard Combe 6

50

Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants

Clin Pharmacol Drug Dev. 2022 Feb;11(2):235-245.doi: 10.1002/cpdd.1015. Epub 2021 Sep 1.

Kacey Anderson 1Cara H Nelson 1Qi Gong 1Muhsen Alani 1 2Thomas Tarnowski 1Ahmed A Othman 1

51

Weight Fluctuation and the Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis

Arthritis Care Res (Hoboken). 2022 Feb;74(2):229-235. doi: 10.1002/acr.24469.Epub 2022 Jan 5.

Joshua F Baker 1George Reed 2Joel Kremer 3

52

Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis

Rheumatol Ther. 2022 Apr;9(2):649-661. doi: 10.1007/s40744-022-00429-w.Epub 2022 Feb 20.

Roy Fleischmann 1Kyle Hayes 2Sung-Woo Ahn 3George J Wan 2Mary Panaccio 2Daniel Karlsson 2Daniel E Furst 4

53

Circulating Adipokines and Associations with Incident Cardiovascular Disease in Rheumatoid Arthritis

Arthritis Care Res (Hoboken). 2022 Mar 21. doi: 10.1002/acr.24885. Online ahead of print.

Lydia E Federico 1Tate M Johnson 2 3Bryant R England 2 3Katherine D Wysham 4 5Michael D George 1 6Brian Sauer 7 8Bartlett C Hamilton 3Carlos D Hunter 3Michael J Duryee 3Geoffrey M Thiele 2 3Ted R Mikuls 2 3Joshua F Baker 1 6 9

54

Investigation Into the Effect of COVID-19 Infection on Length of Hospital Stay and Mortality in Patients With Rheumatoid Arthritis

Cureus. 2022 Feb 28;14(2):e22685. doi: 10.7759/cureus.22685. eCollection 2022 Feb.

Kevin Thompson 1Ami Shah 2Adam Grunbaum 3Olu Oyesanmi 4

55

Alcohol consumption and the risk of mortality and myocardial infarction in patients with rheumatoid arthritis

Clin Exp Rheumatol. 2022 Jan 25. doi: 10.55563/clinexprheumatol/8snr4x. Online ahead of print.

Isaac D Smith 1Na Lu 2Jie Wei 2Yuqing Zhang 2Hyon K Choi 2Marcy B Bolster 2

56

Frequency of symptomatic adverse events in rheumatoid arthritis: an exploratory online survey

J Rheumatol. 2022 Mar 1;jrheum.210688. doi: 10.3899/jrheum.210688. Online ahead of print.

Glen S Hazlewood 1, Orit Schieir 1, Vivian Bykerk 1, Kamso Mujaab 1, Peter Tugwell 1, George Wells 1, Dawn Richards 1, Laurie Proulx 1, Pauline M Hull 1, Susan J Bartlett 1

57

The Use of Telehealth for Psychological Counselling of Vulnerable Adult Patients With Rheumatic Diseases or Diabetes: Explorative Study Inspired by Participatory Design

JMIR Hum Factors. 2022 Mar 21;9(1):e30829. doi: 10.2196/30829.

Mette Juel Rothmann 1 2 3 4, Julie Drotner Mouritsen 1 2, Nanna Skov Ladefoged 1 2, Marie Nedergaard Jeppesen 2, Anna Sofie Lillevang 1 2, Helle Laustrup 1 4, Torkell Ellingsen 1 4

58

Development of a Digital Health Intervention for Rheumatoid Arthritis Symptom Management in a Biotechnology Industry Context: Protocol for the Application of a Human-Centered Design Framework

MIR Res Protoc. 2022 Mar 22;11(3):e16430. doi: 10.2196/16430.

Lisa Nugent # 1, Robin Anthony Kouyate # 1, Shawna Jackson # 1, Meredith Y Smith # 1

59

Oral surveillance and JAK inhibitor safety: the theory of relativity

Nat Rev Rheumatol. 2022 Mar 22;1-4. doi: 10.1038/s41584-022-00767-7.Online ahead of print.

Kevin L Winthrop 1, Stanley B Cohen 2

60

Elevations in Adipocytokines and Mortality in Rheumatoid Arthritis

Rheumatology (Oxford). 2022 Mar 23;keac191. doi: 10.1093/rheumatology/keac191.Online ahead of print.

Joshua F Baker 1 2 3, Bryant R England 4, Michael D George 2 3, Katherine Wysham 5 6, Tate Johnson 4, Gary Kunkel 7, Brian Sauer 7, Bartlett C Hamilton 4, Carlos D Hunter 4, Michael J Duryee 4, Paul Monach 8, Gail Kerr 9, Andreas Reimold 10, Rui Xiao 3, Geoff M Thiele 4, Ted R MIkuls 4

61

Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis

Rheumatol Ther. 2022 Mar 18. doi: 10.1007/s40744-022-00439-8. Online ahead of print.

Roy M Fleischmann 1, Amy E Bock 2, Wuyan Zhang 3, Charles M Godfrey 4, Ivana Vranic 5, Carol Cronenberger 6, Eva Dokoupilová 7 8

62

Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies

J Rheumatol. 2022 Mar 15;jrheum.211242. doi: 10.3899/jrheum.211242. Online ahead of print.

Gregory McDermott 1, Ritu Gill 1, Staci Gagne 1, Suzanne Byrne 1, Weixing Huang 1, Xiaosong Wang 1, Lauren C Prisco 1, Alessandra Zaccardelli 1, Lily W Martin 1, Lucy Masto 1, Vanessa L Kronzer 1, Nancy Shadick 1, Paul F Dellaripa 1, Tracy J Doyle 1, Jeffrey A Sparks 1

63

Presence of Autoantibodies in Males and Females with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

J Rheumatol. 2022 Mar 15;jrheum.211020. doi: 10.3899/jrheum.211020. Online ahead of print.

Brook Hadwen 1, Richard Yu 1, Ewa Cairns 1, Lillian Barra 1

64

Associations of the MUC5B Promoter Variant with Timing of Interstitial Lung Disease and Rheumatoid Arthritis Onset

Rheumatology (Oxford). 2022 Mar 15;keac152. doi: 10.1093/rheumatology/keac152.Online ahead of print.

Gregory McDermott 1 2, Ritu Gill 3 2, Staci Gagne 4 2, Suzanne Byrne 4 2, Weixing Huang 1, Jing Cui 1 2, Lauren Prisco 1, Alessandra Zaccardelli 1, Lily Martin 1, Vanessa L Kronzer 5, Matthew Moll 6 7 2, Michael H Cho 6 7 2, Nancy Shadick 1 2, Paul F Dellaripa 1 2, Tracy Doyle 6 2, Jeffrey A Sparks 1 2

65

Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy

RMD Open. 2022 Mar;8(1):e001994. doi: 10.1136/rmdopen-2021-001994.

Peter C Taylor 1, Rieke Alten 2, Jose María Álvaro Gracia 3, Yuko Kaneko 4, Chad Walls 5, Amanda Quebe 5, Bochao Jia 5, Natalia Bello 5, Jorge Ross Terres 5, Roy Fleischmann 6

66

Microstructural Bone Changes Are Associated With Broad-Spectrum Autoimmunity and Predict the Onset of Rheumatoid Arthritis

Arthritis Rheumatol. 2022 Mar;74(3):418-426. doi: 10.1002/art.41229. Epub 2022 Jan 27.

David Simon 1, Arnd Kleyer 1, Duy Bui Cong 1, Axel Hueber 1, Holger Bang 2, Andreas Ramming 1, Juergen Rech 1, Georg Schett 1

67

Defining Minimum Clinically Important Changes for the Patient Activity Scale II

Arthritis Care Res (Hoboken). 2021 Oct;73(10):1456-1460.doi: 10.1002/acr.24335. Epub 2021 Aug 20.

Joshua F Baker 1, Patti Katz 2, Kaleb Michaud 3

68

Long-term Outcomes of MCP Surface Replacement Arthroplasty in Patients With Rheumatoid Arthritis

Hand (N Y). 2022 Mar;17(2):271-277. doi: 10.1177/1558944720926631. Epub 2020 Jun 2.

Matthew R Claxton 1, Eric R Wagner 2, Marco Rizzo 1

69

Patient-reported outcomes and realistic clinical endpoints for JAK inhibitors in rheumatoid arthritis

Expert Rev Clin Immunol. 2022 Mar 2. doi: 10.1080/1744666X.2022.2049242.Online ahead of print.

Vibeke Strand 1

70

Obesity and Response to Advanced Therapies in Rheumatoid Arthritis

Arthritis Care Res (Hoboken). 2022 Feb 10. doi: 10.1002/acr.24867. Online ahead of print.

Joshua F Baker 1 2 3, George Reed 4, Dilli Ram Poudel 5, Leslie R Harrold 4 6, Joel M Kremer 4 7

71

Recent issues in JAK inhibitor safety: perspective for the clinician

Expert Rev Clin Immunol. 2022 Feb 10;1-13. doi: 10.1080/1744666X.2022.2039122.Online ahead of print.

Roy Fleischmann 1 2

72

Patient Goals for Living with Rheumatoid Arthritis: A Qualitative Study

Clin Nurs Res. 2022 Feb 7;10547738221075784.

doi: 10.1177/10547738221075784.Online ahead of print.

Melanie J Cozad 1, Lisa C Lindley 2, Kaitlyn Crosby 3, Noor Alshareef 4, Ann Blair Kennedy 5, Gulzar Merchant 6, Pam Evans 7, Ronnie D Horner 1

73

Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study

RMD Open. 2022 Feb;8(1):e002012. doi: 10.1136/rmdopen-2021-002012.

Roy Fleischmann 1, Eduardo Mysler 2, Louis Bessette 3, Charles G Peterfy 4, Patrick Durez 5, Yoshiya Tanaka 6, Jerzy Swierkot 7, Nasser Khan 8, Xianwei Bu 8, Yihan Li 8, In-Ho Song 8

74

Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials

Ann Rheum Dis. 2022 Feb;81(2):206-213. doi: 10.1136/annrheumdis-2021-220822.Epub 2021 Oct 6.

Kevin L Winthrop 1Peter Nash 2Kunihiro Yamaoka 3Eduardo Mysler 4Nasser Khan 5Heidi S Camp 5Yanna Song 5Jessica L Suboticki 5Jeffrey R Curtis 6

75

The erratic C-reactive protein: a novel outcome measure for longitudinal disease activity in rheumatoid arthritis

Clin Exp Rheumatol. 2021 Sep 21. Online ahead of print.

Andrew E Thompson 1Janet E Pope 2

76

Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis

Front Immunol. 2021 Sep 14;12:715997. doi: 10.3389/fimmu.2021.715997. eCollection 2021.

Liam J O'Neil 1Christopher B Oliveira 1Donavon Sandoval-Heglund 1Ana Barrera-Vargas 2Javier Merayo-Chalico 2Eduardo Aguirre-Aguilar 2Mariana J Kaplan 1Carmelo Carmona-Rivera 1

77

Filgotinib as rheumatoid arthritis therapy

Drugs Today (Barc). 2021 Sep;57(9):543-550. doi: 10.1358/dot.2021.57.9.3317241.

A Becciolini 1E Di Donato 2D Santilli 2G Lucchini 2F Mozzani 2M Riva 2A Ariani 2

78

Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis

Adv Ther. 2021 Dec;38(12):5649-5661. doi: 10.1007/s12325-021-01930-4. Epub 2021 Oct 12.

Martin Bergman 1Namita Tundia 2Min Yang 3Eli Orvis 3Jerry Clewell 2Arielle Bensimon 4

79

Effects of Extracellular Vesicles from Blood-Derived Products on Osteoarthritic Chondrocytes within an Inflammation Model

Int J Mol Sci. 2021 Jul 5;22(13):7224. doi: 10.3390/ijms22137224.

Alexander Otahal 1Karina Kramer 1Olga Kuten-Pella 2Lukas B Moser 1Markus Neubauer 1Zsombor Lacza 2 3Stefan Nehrer 1Andrea De Luna 1

80

Systematic review of safety and efficacy of belimumab in treating immune-mediated disorders

Allergy. 2021 Sep;76(9):2673-2683. doi: 10.1111/all.14704. Epub 2020 Dec 26.

Celine Kaegi 1Urs C Steiner 1Benjamin Wuest 1Catherine Crowley 1Onur Boyman 1 2

81

Effectiveness of initial methotrexate-based treatment approaches in early rheumatoid arthritis: an elicitation of rheumatologists' beliefs

Rheumatology (Oxford). 2021 Aug 2;60(8):3570-3578.doi: 10.1093/rheumatology/keaa803.

Gyanendra Pokharel 1Rob Deardon 2Sindhu R Johnson 3 4George Tomlinson 4Pauline M Hull 5Glen S Hazlewood 5 6

82

Efficacy, Safety, and Immunogenicity of Biosimilar Etanercept (Enerceptan) Versus Its Original Form in Combination With Methotrexate in Patients With Rheumatoid Arthritis: A Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study

J Clin Rheumatol. 2021 Sep 1;27(6S):S173-S179.doi: 10.1097/RHU.0000000000001616.

Ingrid Strusberg 1Eduardo Mysler 2Gustavo Citera 3Daniel Siri 4Maria de Los Ángeles Correa 5Maria Alicia Lazaro 6Rodolfo Pardo Hidalgo 7Alberto Spindler 8Patricio Tate 9Horacio Venarotti 10Jorge Velasco Zamora 11Ezequiel Klimovsky 12Andrea Federico 12Eduardo Scheines 13Eliseo Gonzalez 14Lucas Cordeiro 15Nestor Lago 15

83

Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease

Rheumatology (Oxford). 2021 Aug 2;60(8):3778-3788. doi: 10.1093/rheumatology/keaa860.

Nadia M T Roodenrijs 1Marlies C van der Goes 1 2Paco M J Welsing 1Janneke Tekstra 1Floris P J G Lafeber 1Johannes W G Jacobs 1Jacob M van Laar 1

84

Patients' and rheumatologists' perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA study

Rheumatology (Oxford). 2021 Jul 1;60(7):3334-3342. doi: 10.1093/rheumatology/keaa785.

T Santiago 1 2M Voshaar 3M de Wit 4P D Carvalho 5 6 7F Buttgereit 8M Cutolo 9S Paolino 9G R Castelar Pinheiro 10M Boers 11J A P Da Silva 1 2

85

Comparison of Clinical Manifestations in Rheumatoid Arthritis vs. Spondyloarthritis: A Systematic Literature Review

Rheumatol Ther. 2021 Dec 28. doi: 10.1007/s40744-021-00407-8.Online ahead of print.

Philip J Mease 1 2Mohit Kumar Bhutani 3Steven Hass 4Esther Yi 5Peter Hur 5Nina Kim 6 7

86

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study

Rheumatology (Oxford). 2021 Jul 1;60(7):3222-3234. doi: 10.1093/rheumatology/keaa771.

Jennifer C E Lane 1James Weaver 2Kristin Kostka 3Talita Duarte-Salles 4Maria Tereza F Abrahao 5Heba Alghoul 6Osaid Alser 7Thamir M Alshammari 8Carlos Areia 9Patricia Biedermann 10Juan M Banda 11Edward Burn 1 4Paula Casajust 12Kristina Fister 13Jill Hardin 2Laura Hester 2George Hripcsak 14 15Benjamin Skov Kaas-Hansen 16 17Sajan Khosla 18Spyros Kolovos 1Kristine E Lynch 19 20Rupa Makadia 2Paras P Mehta 21Daniel R Morales 22Henry Morgan-Stewart 3Mees Mosseveld 23Danielle Newby 24Fredrik Nyberg 25Anna Ostropolets 14Rae Woong Park 26Albert Prats-Uribe 1Gowtham A Rao 2Christian Reich 3Peter Rijnbeek 23Anthony G Sena 2 23Azza Shoaibi 2Matthew Spotnitz 14Vignesh Subbian 27Marc A Suchard 28David Vizcaya 29Haini Wen 30Marcel de Wilde 23Junqing Xie 1Seng Chan You 26Lin Zhang 31 32Simon Lovestone 33Patrick Ryan 2 14Daniel Prieto-Alhambra 1OHDSI-COVID-19 consortium

87

Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology

Clin Exp Rheumatol. Sep-Oct 2021;39(5):1077-1084.Epub 2020 Dec 18.

Francesca Benaglio 1Marco Fornaro 2Carlomaurizio Montecucco 3Bernd Raffeiner 4Manuela Di Franco 5Cristina Iannuccelli 5Paola Conigliaro 6Claudia Lomater 7Marcello Govoni 8Ettore Silvagni 8Anna Zanetti 9Simone Parisi 10Greta Carrara 11Carlo Alberto Scirè 12Florenzo Iannone 2Roberto Caporali 13

88

Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study

Clin Exp Rheumatol. Jul-Aug 2021;39(4):868-873. Epub 2020 Dec 18.

Giacomo Maria Guidelli 1Ombretta Viapiana 2Nicoletta Luciano 1Maria De Santis 1Nicola Boffini 3Luca Quartuccio 4Domenico Birra 5Edoardo Conticini 6Maria Sole Chimenti 7Chiara Bazzani 8Eleonora Bruschi 9Marta Riva 10Lorenzo Maria Canziani 11Gerolamo Bianchi 12Maria Rosa Pozzi 10Massimiliano Limonta 9Roberto Gorla 8Roberto Perricone 7Bruno Frediani 6Paolo Moscato 5Salvatore De Vita 4Lorenzo Dagna 3Maurizio Rossini 2Carlo Selmi 13

89

Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study

Clin Exp Rheumatol. Sep-Oct 2021;39(5):995-1002. Epub 2020 Dec 4.

Piero Ruscitti 1Paola Cipriani 2Vasiliki Liakouli 3Daniela Iacono 3Ilenia Pantano 3Domenico Paolo Emanuele Margiotta 4Luca Navarini 4Giulia Maria Destro Castaniti 5Nicola Maruotti 6Gerardo Di Scala 7Francesco Caso 8Sara Bongiovanni 9Rosa Daniela Grembiale 10Fabiola Atzeni 11Raffaele Scarpa 8Federico Perosa 12Giacomo Emmi 7Francesco Paolo Cantatore 6Giuliana Guggino 5Antonella Afeltra 4Francesco Ciccia 3Roberto Giacomelli 2

90

Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis

Ann Rheum Dis. 2021 Jul;80(7):884-890. doi: 10.1136/annrheumdis-2020-218744.Epub 2021 Jan 12.

Irina Gessl 1Mihaela Popescu 2Victoria Schimpl 3Gabriela Supp 1Thomas Deimel 1Martina Durechova 1Miriam Hucke 4Michaela Loiskandl 1Paul Studenic 1Michael Zauner 1Josef S Smolen 1Daniel Aletaha 1Peter Mandl 5

91

Widespread non-joint pain in early rheumatoid arthritis

Scand J Rheumatol. 2021 Jul;50(4):271-279. doi: 10.1080/03009742.2020.1846778.Epub 2021 Feb 25.

Mec Schelin 1 2H Westerlind 3 4J Lindqvist 5 6E Englid 5L Israelsson 5E Skillgate 3L Klareskog 5 6L Alfredsson 3J Lampa 5 6

92

Higher mortality rates associated with rheumatoid arthritis in Saskatchewan, Canada, 2001-2019

Can J Public Health. 2021 Aug;112(4):722-732. doi: 10.17269/s41997-021-00476-w.Epub 2021 Feb 17.

Regina M Taylor-Gjevre 1Bindu V Nair 2Shan Jin 3Jacqueline Quail 3 4

93

Outcomes of a Mobile App to Monitor Patient-Reported Outcomes in Rheumatoid Arthritis: A Randomized Controlled Trial

Arthritis Rheumatol. 2021 Aug;73(8):1421-1429.doi: 10.1002/art.41686. Epub 2021 Jun 18.

Yvonne C Lee 1Fengxin Lu 2Joshua Colls 2Dee Luo 2Penny Wang 2Dorothy D Dunlop 1Lutfiyya N Muhammad 1Jing Song 1Kaleb Michaud 3Daniel H Solomon 2

94

Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study

Rheumatology (Oxford). 2021 Oct 2;60(10):4681-4690. doi: 10.1093/rheumatology/keab078.

Nadia M T Roodenrijs 1Paco M J Welsing 1Marlies C van der Goes 1 2Janneke Tekstra 1Floris P J G Lafeber 1Johannes W G Jacobs 1Jacob M van Laar 1

95

Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis

Arthritis Rheumatol. 2021 Oct;73(10):1820-1830. doi: 10.1002/art.41744. Epub 2021 Aug 24.

Nicola J Maney 1Henrique Lemos 1Ben Barron-Millar 1Christopher Carey 1Ian Herron 1Amy E Anderson 1Andrew L Mellor 1John D Isaacs 2Arthur G Pratt 2

96

Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation

Arthritis Rheumatol. 2021 Jun;73(6):970-979. doi: 10.1002/art.41613. Epub 2021 May 9.

Brittany Weber 1Zeling He 1Nicole Yang 1Martin P Playford 2Dana Weisenfeld 1Christine Iannaccone 1Jonathan Coblyn 1Michael Weinblatt 1Nancy Shadick 1Marcelo Di Carli 1Nehal N Mehta 2Jorge Plutzky 1Katherine P Liao 3

97

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Arthritis Care Res (Hoboken). 2021 Jul;73(7):924-939. doi: 10.1002/acr.24596. Epub 2021 Jun 8.

Liana Fraenkel 1Joan M Bathon 2Bryant R England 3E William St Clair 4Thurayya Arayssi 5Kristine Carandang 6Kevin D Deane 7Mark Genovese 8Kent Kwas Huston 9Gail Kerr 10Joel Kremer 11Mary C Nakamura 12Linda A Russell 13Jasvinder A Singh 14Benjamin J Smith 15Jeffrey A Sparks 16Shilpa Venkatachalam 17Michael E Weinblatt 16Mounir Al-Gibbawi 18Joshua F Baker 19Kamil E Barbour 20Jennifer L Barton 21Laura Cappelli 22Fatimah Chamseddine 18Michael George 23Sindhu R Johnson 24Lara Kahale 18Basil S Karam 18Assem M Khamis 18Iris Navarro-Millán 25Reza Mirza 26Pascale Schwab 21Namrata Singh 27Marat Turgunbaev 28Amy S Turner 28Sally Yaacoub 18Elie A Akl 18

98

"Associations of Rheumatoid Arthritis and Depressive Symptoms over Time: Are there Differences by Education, Race/Ethnicity, and Gender?"

Arthritis Care Res (Hoboken). 2021 Jun 13. doi: 10.1002/acr.24730. Online ahead of print.

Julia T McQuillan 1Jennifer A Andersen 2Terceira A Berdahl 3Jeff Willett 4

99

The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions

Front Pharmacol. 2021 May 28;12:680043. doi: 10.3389/fphar.2021.680043.eCollection 2021.

Shahin Shams 1Joseph M Martinez 2John R D Dawson 3Juan Flores 4Marina Gabriel 1Gustavo Garcia 1Amanda Guevara 2Kaitlin Murray 5Noah Pacifici 1Maxemiliano V Vargas 6Taylor Voelker 3Johannes W Hell 2Judith F Ashouri 7

100

The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis

Cardiovasc Endocrinol Metab. 2021 Feb 19;10(2):125-131.doi: 10.1097/XCE.0000000000000244. eCollection 2021 Jun.

Zixing Tian 1John Mclaughlin 1Arpana Verma 2Hector Chinoy 3 4 5Adrian H Heald 1 1

101

2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Arthritis Rheumatol. 2021 Jul;73(7):1108-1123. doi: 10.1002/art.41752. Epub 2021 Jun 8

Liana Fraenkel 1Joan M Bathon 2Bryant R England 3E William St Clair 4Thurayya Arayssi 5Kristine Carandang 6Kevin D Deane 7Mark Genovese 8Kent Kwas Huston 9Gail Kerr 10Joel Kremer 11Mary C Nakamura 12Linda A Russell 13Jasvinder A Singh 14Benjamin J Smith 15Jeffrey A Sparks 16Shilpa Venkatachalam 17Michael E Weinblatt 16Mounir Al-Gibbawi 18Joshua F Baker 19Kamil E Barbour 20Jennifer L Barton 21Laura Cappelli 22Fatimah Chamseddine 18Michael George 23Sindhu R Johnson 24Lara Kahale 18Basil S Karam 18Assem M Khamis 18Iris Navarro-Millán 25Reza Mirza 26Pascale Schwab 21Namrata Singh 27Marat Turgunbaev 28Amy S Turner 28Sally Yaacoub 18Elie A Akl 18

102

Multimorbidity Accrual After Incident Rheumatoid Arthritis: A Wolf at the Door

J Rheumatol. 2021 Jun 1;jrheum.210224. doi: 10.3899/jrheum.210224.Online ahead of print.

Jeffrey A Sparks 1

103

Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United Kingdom

Rheumatology (Oxford). 2021 Jun 3;keab464. doi: 10.1093/rheumatology/keab464.Online ahead of print.

Peter C Taylor 1Matthew Woods 2Catherine Rycroft 2Priya Patel 3Sophee Blanthorn-Hazell 3Toby Kent 3Marwan Bukhari 4

104

What Is the Persistence to Methotrexate in Rheumatoid Arthritis, and Does Machine Learning Outperform Hypothesis-Based Approaches to Its Prediction?

ACR Open Rheumatol. 2021 Jul;3(7):457-463. doi: 10.1002/acr2.11266. Epub 2021 Jun 4.

Helga Westerlind 1Mateusz Maciejewski 2Thomas Frisell 1Scott A Jelinsky 2Daniel Ziemek 2Johan Askling 1

105

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

Ann Rheum Dis. 2021 May 28;annrheumdis-2021-220418.doi: 10.1136/annrheumdis-2021-220418. Online ahead of print.

Jeffrey A Sparks # 1 2Zachary S Wallace # 3 4Andrea M Seet 5Milena A Gianfrancesco 5Zara Izadi 6Kimme L Hyrich 7 8Anja Strangfeld 9Laure Gossec 10 11Loreto Carmona 12Elsa F Mateus 13 14Saskia Lawson-Tovey 15 16Laura Trupin 5Stephanie Rush 5Patricia Katz 5Gabriela Schmajuk 5 17Lindsay Jacobsohn 5Leanna Wise 18Emily L Gilbert 19Ali Duarte-García 20Maria O Valenzuela-Almada 21Guillermo J Pons-Estel 22Carolina A Isnardi 22Guillermo A Berbotto 23Tiffany Y-T Hsu 24Kristin M D'Silva 4Naomi J Patel 4Lianne Kearsley-Fleet 7Martin Schäfer 9Sandra Lúcia Euzébio Ribeiro 25Samar Al Emadi 26Liselotte Tidblad 27Carlo Alberto Scirè 28Bernd Raffeiner 29Thierry Thomas 30René-Marc Flipo 31Jérôme Avouac 32Raphaèle Seror 33Miguel Bernardes 34 35Maria Margarida Cunha 36

106

Risk of COVID-19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At-Risk Individuals

Arthritis Rheumatol. 2021 May 5;10.1002/art.41800. doi: 10.1002/art.41800. Online ahead of print.

Bryant R England 1 2Punyasha Roul 2Yangyuna Yang 2Andre C Kalil 3Kaleb Michaud 2 4Geoffrey M Thiele 1 2Brian C Sauer 5Joshua F Baker 6Ted R Mikuls 1 2

107

Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests

J Rheumatol. 2021 May 15;jrheum.201510. doi: 10.3899/jrheum.201510.Online ahead of print.

Johannes W G Jacobs 1Maxime M A Verhoeven 1Paco M J Welsing 1

108

Systematic review and meta-analysis of the reproducibility of patient self-reported joint counts in rheumatoid arthritis

J Rheumatol. 2021 May 15;jrheum.201439. doi: 10.3899/jrheum.201439. Online ahead of print.

Sanketh Rampes 1Vishit Patel 1Ailsa Bosworth 1Clare Jacklin 1Deepak Nagra 1Mark Yates 1Sam Norton 1James Galloway 1

109

Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis

Front Immunol. 2021 Apr 29;12:673916. doi: 10.3389/fimmu.2021.673916.eCollection 2021.

Sally A Clayton 1 2Lucy MacDonald 3 4Mariola Kurowska-Stolarska 3 4Andrew R Clark 1 2

110

Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis

Ann Rheum Dis. 2021 May 28;annrheumdis-2021-220125.doi: 10.1136/annrheumdis-2021-220125. Online ahead of print.

Tate M Johnson 1 2Harlan R Sayles 1 3Joshua F Baker 4 5Michael D George 4 5Punyasha Roul 1Cheng Zheng 3Brian Sauer 6 7Katherine P Liao 8Daniel R Anderson 9Ted R Mikuls 1 2Bryant R England 10 2

111

Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine Learning

J Rheumatol. 2021 May 1;jrheum.201626. doi: 10.3899/jrheum.201626. Online ahead of print.

Fredrik D Johansson 1Jamie E Collins 1Vincent Yau 1Hongshu Guan 1Seoyoung C Kim 1Elena Losina 1David Sontag 1Jacklyn Stratton 1Huong Trinh 1Jeffrey Greenberg 1Daniel H Solomon 1

112

The utility of therapeutic plasma exchange in Hyperviscosity syndrome associated with juvenile rheumatoid arthritis: A case report

J Clin Apher. 2021 May 4. doi: 10.1002/jca.21903. Online ahead of print.

Allen P Green 1Adam C Gonzalez 2Jack B Alperin 3James D Burner 1Sean G Yates 1

113

Clinical use of Jak 1 inhibitors for rheumatoid arthritis

Rheumatology (Oxford). 2021 May 5;60(Supplement_2):ii31-ii38.doi: 10.1093/rheumatology/keab265.

Peter Nash 1

114

Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis

Rheumatology (Oxford). 2021 May 5;60(Supplement_2):ii17-ii23.doi: 10.1093/rheumatology/keaa823.

Eduardo Mysler 1Ana Lizarraga 1

115

Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort

Int Immunopharmacol. 2021 Apr 29;97:107719. doi: 10.1016/j.intimp.2021.107719.Online ahead of print.

Bryant R England 1Megan Campany 2Harlan Sayles 2Punyasha Roul 2Yangyuna Yang 2Apar Kishor Ganti 3Jeremy Sokolove 4William H Robinson 5Andreas M Reimold 6Gail S Kerr 7Grant W Cannon 8Brian C Sauer 8Joshua F Baker 9Geoffrey M Thiele 10Ted R Mikuls 10

116

Identification and Evaluation of Serum Protein Biomarkers Which Differentiate Psoriatic from Rheumatoid Arthritis

Arthritis Rheumatol. 2021 Jun 11. doi: 10.1002/art.41899. Online ahead of print.

Angela Mc Ardle 1Anna Kwasnik 1Agnes Szenpetery 1Belinda Hernandez 2 3Andrew Parnell 3Wilco de Jager 4 5Sytze de Roock 5Oliver FitzGerald 1Stephen R Pennington 1

117

Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study

Medicine (Baltimore). 2021 Apr 30;100(17):e25481. doi: 10.1097/MD.0000000000025481.

Alberto Floris 1Daniela Perra 1Ignazio Cangemi 1Mattia Congia 1Elisabetta Chessa 1Maria Maddalena Angioni 1Arduino Aleksander Mangoni 2Gian Luca Erre 3Alessandro Mathieu 1Matteo Piga 1Alberto Cauli 3

118

Clinical and biomechanical factors associated with falls and rheumatoid arthritis: baseline cohort with longitudinal nested case-control study

Rheumatology (Oxford). 2021 Apr 26;keab388. doi: 10.1093/rheumatology/keab388.Online ahead of print.

Toby O Smith 1 2Celia Clarke 1Jack R Dainty 1Laura Watts 1Max Yates 1 3Valerie M Pomeroy 1 4Emma Stanmore 5Terence W O'Neill Tw 6Alexander J Macgregor 1 3

119

Perioperative Management of Antirheumatic Medications in Patients with RA and SLE Undergoing Elective Foot and Ankle Surgery: A Critical Analysis Review

JBJS Rev. 2021 Jun 8;9(6). doi: 10.2106/JBJS.RVW.20.00201.

Noah E Saunders 1James R Holmes 2David M Walton 2Paul G Talusan 3

120

Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift)

RMD Open. 2021 Jun;7(2):e001673. doi: 10.1136/rmdopen-2021-001673.

Stanley B Cohen 1Janet Pope 2Boulos Haraoui 3Eduardo Mysler 4Annette Diehl 5Tatjana Lukic 6Shixue Liu 7Lori Stockert 5Rebecca Germino 6Sujatha Menon 8Harry Shi 6Edward C Keystone 9

121

Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors

Rheumatology (Oxford). 2021 Apr 19;keab355. doi: 10.1093/rheumatology/keab355.Online ahead of print.

Roy Fleischmann 1Mark C Genovese 2Karina Maslova 3Henry Leher 4Amy Praestgaard 5Gerd R Burmester 6

122

Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial

RMD Open. 2021 Apr;7(1):e001627. doi: 10.1136/rmdopen-2021-001627.

Juliana Rachel Hoeper 1 2Jan Zeidler 1Sara Eileen Meyer 2Georg Gauler 3Patricia Steffens-Korbanka 3Martin Welcker 4Jörg Wendler 5Florian Schuch 5Ulrich von Hinüber 6Andreas Schwarting 7 8Torsten Witte 2Dirk Meyer-Olson 2 9Kirsten Hoeper 10

123

Demyelinating Events Following Initiation of Anti-TNFa Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis

Neurol Neuroimmunol Neuroinflamm. 2021 Apr 16;8(3):e992.doi: 10.1212/NXI.0000000000000992. Print 2021 May.

Thomas R P Taylor 1James Galloway 1Rebecca Davies 1Kimme Hyrich 1Ruth Dobson 2

124

Epstein-Barr virus -related lymphoma in rheumatoid arthritis: Implications for long-term usage of immunosuppressive drugs and review of the literature

Intern Med J. 2021 May 24. doi: 10.1111/imj.15390. Online ahead of print.

Jianna He 1Luke Williamson 1Ken Cai 1Peter Wong 1 2Allan Sturgess 3John Taper 4Nicholas Manolios 1 5

125

Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study

Rheumatol Ther. 2021 May 24. doi: 10.1007/s40744-021-00317-9. Online ahead of print.

Alvin F Wells 1Bochao Jia 2Li Xie 2Guillermo J Valenzuela 3Edward C Keystone 4Zhanguo Li 5Amanda K Quebe 6Kirstin Griffing 2Susan Otawa 2Boulos Haraoui 7

126

Few Adverse Cardiovascular Events among Patients with Rheumatoid Arthritis Receiving Hydroxychloroquine: Are We Reassured?

Arthritis Rheumatol. 2021 May 13. doi: 10.1002/art.41801. Online ahead of print.

Candace H Feldman 1Mark S Link 2

127

Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID19 Pandemic in a Community Practice-Based Network

Arthritis Care Res (Hoboken). 2021 May 10. doi: 10.1002/acr.24626. Online ahead of print.

Michael George 1Maria I Danila 2Daniel Watrous 3Shanmugapriya Reddy 4Jeffrey Alper 5Fenglong Xie 2W Benjamin Nowell 6Joel Kallich 7Cassie Clinton 2Kenneth G Saag 2Jeffrey R Curtis 2

128

Meaningful change thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) fatigue and pain interference scores in patients with rheumatoid arthritis

J Rheumatol. 2021 Mar 15;jrheum.200990. doi: 10.3899/jrheum.200990. Online ahead of print.

Jennifer L Beaumont 1Elizabeth S Davis 1James F Fries 1Jeffrey R Curtis 1David Cella 1Huifeng Yun 1

129

Role of Janus Kinase inhibitors in rheumatoid arthritis treatment

Curr Opin Rheumatol. 2021 May 1;33(3):300-306. doi: 10.1097/BOR.0000000000000792.

Virginia Reddy 1 2Stanley Cohen 1 3 4

130

Probabilistic Linkage of Randomized Controlled Trial Data to Administrative Claims: A Case Study of Patients from Baricitinib Clinical Trials

Rheumatol Ther. 2021 Apr 2. doi: 10.1007/s40744-021-00302-2. Online ahead of print.

Catherine B McGuiness 1Natalie N Boytsov 2Xiang Zhang 2Xin Wang 3Carol L Kannowski 2Rolin L Wade 3

131

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry

Rheumatol Ther. 2021 Mar;8(1):467-481. doi: 10.1007/s40744-021-00285-0. Epub 2021 Feb 25.

Dimitrios A Pappas 1Taylor Blachley 2Jennie H Best 3Steve Zlotnick 3William G Reiss 3Kelechi Emeanuru 2Joel M Kremer 2 4

132

The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease

Health Psychol Open. 2020 Dec 8;7(2):2055102920971496. doi: 10.1177/2055102920971496.eCollection Jul-Dec 2020.

Livia Savarese 1Maria Francesca Freda 1Raffaele De Luca Picione 2Pasqaule Dolce 3Raffaella De Falco 4Maria Alessio 5Mauro Cancian 6Adriana Franzese 5Maria Domenica Guarino 7Roberto Perricone 7Angelica Petraroli 8Riccardo Senter 1Claudia Traverso 5Andrea Zanichelli 9Eugenio Zito 10Maria Bova 5

133

Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups

J Clin Med. 2021 Apr 1;10(7):1403. doi: 10.3390/jcm10071403.

Barbara Hauser 1 2Nerea Alonso 2Philip L Riches 1 2

134

Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry

Rheumatol Ther. 2021 Mar;8(1):467-481. doi: 10.1007/s40744-021-00285-0. Epub 2021 Feb 25.

Dimitrios A Pappas 1Taylor Blachley 2Jennie H Best 3Steve Zlotnick 3William G Reiss 3Kelechi Emeanuru 2Joel M Kremer 2 4

135

The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease

Health Psychol Open. 2020 Dec 8;7(2):2055102920971496. doi: 10.1177/2055102920971496.eCollection Jul-Dec 2020.

Livia Savarese 1Maria Francesca Freda 1Raffaele De Luca Picione 2Pasqaule Dolce 3Raffaella De Falco 4Maria Alessio 5Mauro Cancian 6Adriana Franzese 5Maria Domenica Guarino 7Roberto Perricone 7Angelica Petraroli 8Riccardo Senter 1Claudia Traverso 5Andrea Zanichelli 9Eugenio Zito 10Maria Bova 5

136

Discrepancy Between Multi-Biomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis

Arthritis Care Res (Hoboken). 2021 Feb 28. doi: 10.1002/acr.24583. Online ahead of print.

Roy Fleischmann 1Jingyu Liu 2Julie Zhu 2Oscar G Segurado 3Daniel E Furst 4

137

The association between increased body mass index and response to conventional synthetic DMARD treatment in rheumatoid arthritis: Results from the METEOR database

Rheumatology (Oxford). 2021 Apr 30;keab389. doi: 10.1093/rheumatology/keab389.Online ahead of print.

Mrinalini Dey 1 2Sizheng S Zhao 1 2Robert J Moots 2 3Sytske Anne Bergstra 4Robert B Landewe 5 6Nicola J Goodson 2

138

Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial

ACR Open Rheumatol. 2021 May 1. doi: 10.1002/acr2.11256. Online ahead of print.

Jon T Giles 1Pamela M Rist 2Katherine P Liao 2Ahmed Tawakol 3Zahi A Fayad 4Venkatesh Mani 4Nina P Paynter 2Paul M Ridker 2Robert J Glynn 2Fengxin Lu 5Rachel Broderick 1Meredith Murray 5Kathleen M M Vanni 5Daniel H Solomon 2Joan M Bathon 1

139

Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic

Expert Rev Clin Immunol. 2021 Apr 14;1-11. doi: 10.1080/1744666X.2021.1908887.Online ahead of print.

Ennio Giulio Favalli 1Gabriella Maioli 1Martina Biggioggero 1Roberto Caporali 1 2

140

Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in a Large International Rheumatoid Arthritis Cohort: SENSE Study

Patient Prefer Adherence. 2021 Feb 17;15:359-373. doi: 10.2147/PPA.S289692. eCollection 2021.

Peter C Taylor 1Codrina Ancuta 2Orsolya Nagy 3María C de la Vega 4Andrey Gordeev 5Radka Janková 6Umut Kalyoncu 7Ivan Lagunes-Galindo 3Jadranka Morovic-Vergles 8Mariana Peixoto G U E Silva de Souza 9Bernadette Rojkovich 10Prodromos Sidiropoulos 11Atsushi Kawakami 12

141

Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof

J Med Chem. 2021 Feb 25;64(4):2228-2241. doi: 10.1021/acs.jmedchem.0c01952.Epub 2021 Feb 11.

Ryan R Davis 1Baoli Li 1Sang Y Yun 2Alice Chan 1Pradeep Nareddy 1Steven Gunawan 1Muhammad Ayaz 2Harshani R Lawrence 2Gary W Reuther 3Nicholas J Lawrence 1Ernst Schönbrunn 1

142

Managing Cardiovascular Risk in Patients with Rheumatic Disease

Med Clin North Am. 2021 Mar;105(2):247-262. doi: 10.1016/j.mcna.2020.09.010.Epub 2021 Jan 14.

Lyn D Ferguson 1Naveed Sattar 2Iain B McInnes 3

143

Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights

Expert Rev Clin Pharmacol. 2021 Apr 13;1-10. doi: 10.1080/17512433.2021.1913050.Online ahead of print.

Maria Gabriella Raimondo 1Martina Biggioggero 2Lavinia Agra Coletto 3Andreas Ramming 1Roberto Caporali 2 3Ennio Giulio Favalli 2

144

Current treatment strategies in rheumatoid arthritis after methotrexate are not enough to maintain sustained remission: There is no holy grail!

Arthritis Rheumatol. 2021 Mar 28. doi: 10.1002/art.41746. Online ahead of print.

Janet E Pope 1Peter Nash 2Roy Fleischmann 3

145

Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study

Osteoporos Int. 2021 Feb 11. doi: 10.1007/s00198-021-05862-1. Online ahead of print.

J Erwin 1D G Enki 2A D Woolf 3

146

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871.Epub 2020 May 29.

Milena Gianfrancesco # 1Kimme L Hyrich # 2 3Sarah Al-Adely 2 3Loreto Carmona 4Maria I Danila 5Laure Gossec 6 7Zara Izadi 1Lindsay Jacobsohn 1Patricia Katz 1Saskia Lawson-Tovey 3 8Elsa F Mateus 9Stephanie Rush 1Gabriela Schmajuk 1Julia Simard 10Anja Strangfeld 11Laura Trupin 1Katherine D Wysham 12Suleman Bhana 13Wendy Costello 14Rebecca Grainger 15Jonathan S Hausmann 16 17Jean W Liew 12Emily Sirotich 18 19Paul Sufka 20Zachary S Wallace 17 21Jinoos Yazdany # 1Pedro M Machado # 22 23 24Philip C Robinson # 25 26COVID-19 Global Rheumatology Alliance

147

Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry

ACR Open Rheumatol. 2021 Mar;3(3):173-184. doi: 10.1002/acr2.11232. Epub 2021 Feb 11.

Joel M Kremer 1Clifton O Bingham 3rd 2Laura C Cappelli 2Jeffrey D Greenberg 3Ann M Madsen 4Jamie Geier 4Jose L Rivas 5Alina M Onofrei 6Christine J Barr 6Dimitrios A Pappas 7Heather J Litman 6Kimberly J Dandreo 6Andrea B Shapiro 8Carol A Connell 9Arthur Kavanaugh 10

148

The Online Sharing of Instagram Images for Rheumatoid Arthritis

Comput Inform Nurs. 2020 Jul 24;39(2):89-96. doi: 10.1097/CIN.0000000000000660.

Deborah Lewis 1Janice LongNancy MossEileen R Fowles

149

The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review

J Clin Med. 2021 Feb 1;10(3):509. doi: 10.3390/jcm10030509.

Peter C Taylor 1Fabiola Atzeni 2Alejandro Balsa 3Laure Gossec 4 5Ulf Müller-Ladner 6Janet Pope 7

150

Peripheral Ulcerative Keratitis in Rheumatoid Arthritis Patients Taking Tocilizumab: Paradoxical Manifestation or Insufficient Efficacy?

Rheumatology (Oxford). 2021 Feb 2;keab093. doi: 10.1093/rheumatology/keab093.Online ahead of print.

Florian Cohen 1Eric Ernest Gabison 2Sophie Stéphan 2Rakiba Belkhir 3Gaetane Nocturne 3 4Anne-Laurence Best 1Oscar Haigh 4Emmanuel Barreau 1Marc Labetoulle 1 4Raphaele Seror 3Antoine Rousseau 1 4

151

Upadacitinib in Rheumatoid Arthritis: A Benefit-Risk Assessment Across a Phase III Program

Drug Saf. 2021 Feb 2. doi: 10.1007/s40264-020-01036-w. Online ahead of print.

Philip G Conaghan 1Eduardo Mysler 2Yoshiya Tanaka 3Barbara Da Silva-Tillmann 4Tim Shaw 5John Liu 4Ryan Ferguson 4Jeffrey V Enejosa 4Stanley Cohen 6Peter Nash 7William Rigby 8Gerd Burmester 9

152

Location, location, location: how the tissue microenvironment affects inflammation in RA

Nat Rev Rheumatol. 2021 Feb 1. doi: 10.1038/s41584-020-00570-2.Online ahead of print.

Christopher D Buckley 1 2Caroline Ospelt 3Steffen Gay 3Kim S Midwood 4

153

Safety and Efficacy of Filgotinib: Up to 4-Year Results From an Open-Label Extension Study of Phase 2 Rheumatoid Arthritis Programs

J Rheumatol. 2021 Feb 1;jrheum.201183. doi: 10.3899/jrheum.201183. Online ahead of print.

Arthur Kavanaugh 1Rene R Westhovens 1Kevin L Winthrop 1Susan J Lee 1YingMeei Tan 1Di An 1Lei Ye 1John S Sundy 1Robin Besuyen 1Luc Meuleners 1Mykola Stanislavchuk 1Alberto J Spindler 1Maria Greenwald 1Rieke Alten 1Mark C Genovese 1

 

154

Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US

Rheumatol Ther. 2021 Jan 23. doi: 10.1007/s40744-020-00275-8. Online ahead of print.

Alison Walton 1Jim Paik 2Amanda Quebe 2Carol L Kannowski 2Casey Choong 2Seth Anderson 2Justin K Owensby 3

155

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Lancet. 2021 Jan 23;397(10271):305-317.doi: 10.1016/S0140-6736(20)32341-2.

Frances Humby 1Patrick Durez 2Maya H Buch 3Myles J Lewis 1Hasan Rizvi 4Felice Rivellese 1Alessandra Nerviani 1Giovanni Giorli 5Arti Mahto 6Carlomaurizio Montecucco 7Bernard Lauwerys 2Nora Ng 8Pauline Ho 9Michele Bombardieri 1Vasco C Romão 10Patrick Verschueren 11Stephen Kelly 12Pier Paolo Sainaghi 13Nagui Gendi 14Bhaskar Dasgupta 15Alberto Cauli 16Piero Reynolds 17Juan D Cañete 18Robert Moots 19Peter C Taylor 20Christopher J Edwards 21John Isaacs 22Peter Sasieni 23Ernest Choy 24Costantino Pitzalis 25R4RA collaborative group

156

Corticosteroids: Review of the History, the Effectiveness, and Adverse Effects in the Treatment of Joint Pain

Pain Physician. 2021 Jan;24(S1):S233-S246.

Shane Stone 1Gerard A Malanga 2Teresa Capella 3

157

Pain and fatigue are longitudinally and bi-directionally associated with more sedentary time and less standing time in rheumatoid arthritis

Rheumatology (Oxford). 2021 Jan 25;keab029. doi: 10.1093/rheumatology/keab029.Online ahead of print.

Ciara M O'Brien 1 2Nikos Ntoumanis 3Joan L Duda 1George D Kitas 2Jet J C S Veldhuijzen van Zanten 1 2George S Metsios 2 4Sally A M Fenton 1 2

158

Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review

Rheumatol Int. 2021 Jan 29. doi: 10.1007/s00296-020-04773-4. Online ahead of print.

Julie K Dawson 1Edmond Quah 2Ben Earnshaw 2Constanta Amoasii 2Tareg Mudawi 2Lisa G Spencer 3

159

Erectile Dysfunction and Cardiovascular Risk in Men with Rheumatoid Arthritis: A Population- Based Cohort Study

J Rheumatol. 2021 Jan 15;jrheum.201226. doi: 10.3899/jrheum.201226. Online ahead of print.

Katelynn M Wilton 1Sara J Achenbach 1John M Davis 3rd 1Elena Myasoedova 1Eric L Matteson 1Cynthia S Crowson 1

160

Development of a Patient-centered Quality Measurement Framework for Measuring, Monitoring, and Optimizing Rheumatoid Arthritis Care in Canada

J Rheumatol. 2020 Sep 1;jrheum.200688. doi: 10.3899/jrheum.200688. Online ahead of print.

Claire E H Barber 1Karen L Then 1Victoria Bohm 1Marc Hall 1Deborah A Marshall 1James A Rankin 1Cheryl Barnabe 1Glen S Hazlewood 1Linda C Li 1Dianne Mosher 1Joanne Homik 1Paul MacMullan 1Karen Tsui 1Kelly English 1Diane LacailleRA Quality Measurement Delphi Panel Group

161

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

Ann Rheum Dis. 2021 Jan 15;annrheumdis-2020-219213.doi: 10.1136/annrheumdis-2020-219213. Online ahead of print.

René Westhovens 1 2William F C Rigby 3Désirée van der Heijde 4Daniel W T Ching 5William Stohl 6Jonathan Kay 7 8Arvind Chopra 9Beatrix Bartok 10Franziska Matzkies 10Zhaoyu Yin 10Ying Guo 10Chantal Tasset 11John S Sundy 10 12Angelika Jahreis 10Neelufar Mozaffarian 13Osvaldo Daniel Messina 14 15Robert Bm Landewé 16 17Tatsuya Atsumi 18Gerd R Burmester 19 20

162

Is gene expression among women with rheumatoid arthritis dysregulated during a postpartum flare?

Arthritis Res Ther. 2021 Jan 18;23(1):30. doi: 10.1186/s13075-021-02418-w.

Matthew Wright 1Mette K Smed 2J Lee Nelson 3 4Jørn Olsen 5 6Merete L Hetland 7 8Vibeke Zoffmann 2 9Damini Jawaheer 10 11

163

Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients

Rheumatology (Oxford). 2021 Jan 18;keaa836. doi: 10.1093/rheumatology/keaa836.Online ahead of print.

Jeffrey A Sparks 1 2Yinzhu Jin 3Soo-Kyung Cho 4Seanna Vine 3Rishi Desai 2 3Tracy J Doyle 2 5Seoyoung C Kim 1 2 3

164

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab

Biologics. 2021 Jan 6;15:1-15. doi: 10.2147/BTT.S285610. eCollection 2021.

Timothy Fitzgerald 1Richard Melsheimer 2Marie-Hélène Lafeuille 3Patrick Lefebvre 3Laura Morrison 3Kimberly Woodruff 1Iris Lin 1Bruno Emond 3

165

Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis

Rheumatology (Oxford). 2021 Jan 12;keaa834. doi: 10.1093/rheumatology/keaa834.Online ahead of print.

Andrew R Melville 1 2Md Yuzaiful Md Yusof 1 2John Fitton 1 2Leticia Garcia-Montoya 1 2Lynda Bailey 3Shouvik Dass 1 2Paul Emery 1 2Maya H Buch 1 4Benazir Saleem 3

166

Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data

Arthritis Res Ther. 2021 Jan 11;23(1):17. doi: 10.1186/s13075-020-02399-2.

Teresa A Simon 1 2Lixian Dong 3Kevin L Winthrop 4

167

Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis

BMC Musculoskelet Disord. 2021 Jan 8;22(1):47. doi: 10.1186/s12891-020-03917-8.

Alison Hammond 1Yeliz Prior 2Sarah Cotterill 3Chris Sutton 3Elizabeth Camacho 4Calvin Heal 3Jo Adams 5Yvonne Hough 6Terence W O'Neill 7 8Jill Firth 9

168

Thoracic Manifestations of Rheumatoid Arthritis

Radiographics. Jan-Feb 2021;41(1):32-55. doi: 10.1148/rg.2021200091.

Lauren K Groner 1Daniel B Green 1Stacey V Weisman 1Alan C Legasto 1Dennis Toy 1James F Gruden 1Joanna G Escalon 1

169

Current Management of Trigger Digit in Rheumatoid Arthritis Patients: A Survey of ASSH Members

Hand (N Y). 2020 Dec 29;1558944720975137. doi: 10.1177/1558944720975137.Online ahead of print.

Rebecca Bickham 1, Logan Carr 2, James Butterfield 1, Brittany Behar 3, Ann-Marie Dyer 1, Alexander Payatakes 1

170

Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses

BMJ Open. 2020 Dec 31;10(12):e041420. doi: 10.1136/bmjopen-2020-041420.

Carlos Alves 1 2, Ana Penedones 2, Diogo Mendes 2, Francisco Batel-Marques 3 2

171

Statins and lower mortality in rheumatic diseases: An effect of immortal time bias?

Semin Arthritis Rheum. 2020 Dec 19;51(1):211-218.doi: 10.1016/j.semarthrit.2020.11.010. Online ahead of print.

Devin Abrahami 1, Marie Hudson 2, Samy Suissa 3

172

C-reactive protein and implications in rheumatoid arthritis and associated comorbidities

Semin Arthritis Rheum. 2020 Dec 17;51(1):219-229.doi: 10.1016/j.semarthrit.2020.11.005. Online ahead of print.

Janet E Pope 1, Ernest H Choy 2

173

The feasibility of an exercise intervention to improve sleep (time, quality and disturbance) in people with rheumatoid arthritis: a pilot RCT

Rheumatol Int. 2021 Jan 2. doi: 10.1007/s00296-020-04760-9. Online ahead of print.

Sean G McKenna 1 2, Alan Donnelly 3 4, Bente Appel Esbensen 5 6, Laura Comber 7, Wan Lin Ng 8, Aqeel Maqsoon Anjum 8, Alexander Fraser 8, Norelee M Kennedy 7 4

174

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study

Rheumatology (Oxford). 2020 Dec 25;keaa771. doi: 10.1093/rheumatology/keaa771.Online ahead of print.

Jennifer C E Lane 1, James Weaver 2, Kristin Kostka 3, Talita Duarte-Salles 4, Maria Tereza F Abrahao 5, Heba Alghoul 6, Osaid Alser 7, Thamir M Alshammari 8, Carlos Areia 9, Patricia Biedermann 10, Juan M Banda 11, Edward Burn 1 4, Paula Casajust 12, Kristina Fister 13, Jill Hardin 2, Laura Hester 2, George Hripcsak 14 15, Benjamin Skov Kaas-Hansen 16 17, Sajan Khosla 18, Spyros Kolovos 1, Kristine E Lynch 19 20, Rupa Makadia 2, Paras P Mehta 21, Daniel R Morales 22, Henry Morgan-Stewart 3, Mees Mosseveld 23, Danielle Newby 24, Fredrik Nyberg 25, Anna Ostropolets 14, Rae Woong Park 26, Albert Prats-Uribe 1, Gowtham A Rao 2, Christian Reich 3, Peter Rijnbeek 23, Anthony G Sena 2 23, Azza Shoaibi 2, Matthew Spotnitz 14, Subbian Vignesh 27, Marc A Suchard 28, David Vizcaya 29, Haini Wen 30, Marcel de Wilde 23, Junqing Xie 1, Seng Chan You 26, Lin Zhang 31 32, Simon Lovestone 33, Patrick Ryan 2 14, Daniel Prieto-Alhambra 1, OHDSI-COVID-19 consortium

175

Associations between an expanded autoantibody profile and treatment responses to biologic therapies in patients with rheumatoid arthritis

Int Immunopharmacol. 2020 Dec 23;91:107260. doi: 10.1016/j.intimp.2020.107260.Online ahead of print.

Alison D Petro 1, Joseph Dougherty 2, Bryant R England 3, Harlan Sayles 4, Michael J Duryee 5, Carlos D Hunter 6, Joel M Kremer 7, Dimitrios A Pappas 8, William H Robinson 9, Jeffrey R Curtis 10, Geoffrey M Thiele 11, Ted R Mikuls 12

176

The Story Behind the Use of Glucocorticoids in the Treatment of Rheumatoid Arthritis

Semin Arthritis Rheum. 2020 Dec 17;51(1):15-19.doi: 10.1016/j.semarthrit.2020.09.016. Online ahead of print.

Doyt L Conn 1

177

Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease

Rheumatology (Oxford). 2020 Dec 17;keaa860. doi: 10.1093/rheumatology/keaa860.Online ahead of print.

Nadia M T Roodenrijs 1, Marlies C van der Goes 1 2, Paco M J Welsing 1, Janneke Tekstra 1, Floris P J G Lafeber 1, Johannes W G Jacobs 1, Jacob M van Laar 1

178

Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway

Rheumatology (Oxford)2020 Dec 17;keaa858. doi: 10.1093/rheumatology/keaa858.Online ahead of print.

John Fitton 1 2, Andrew R Melville 1 2, Paul Emery 1 2, Jacqueline L Nam 1 2, Maya H Buch 1 3

179

Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience

Clin Exp Rheumatol. 2020 Dec 18. Online ahead of print.

Francesca Romana Spinelli 1, Fulvia Ceccarelli 2, Cristina Garufi 2, Ilaria Duca 2, Silvia Mancuso 2, Enrica Cipriano 2, Elisabetta Dell'Unto 2, Cristiano Alessandri 2, Manuela Di Franco 2, Carlo Perricone 3, Roberta Priori 2, Valeria Riccieri 2, Rossana Scrivo 2, Antonio Sili Scavalli 2, Simona Truglia 2, Guido Valesini 2, Fabrizio Conti 2

180

Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons

Front Med (Lausanne). 2020 Nov 23;7:601618. doi: 10.3389/fmed.2020.601618.eCollection 2020.

Irene Llorente 1, Noelia García-Castañeda 1, Cristina Valero 1, Isidoro González-Álvaro 1, Santos Castañeda 1 2

181

Rheumatoid arthritis medication adherence in a health system specialty pharmacy

Am J Manag Care. 2020 Dec 1;26(12):e380-e387. doi: 10.37765/ajmc.2020.88544.

Nate Berger 1, Megan Peter, Josh DeClercq, Leena Choi, Autumn D Zuckerman